The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)
http://clinicaltrials.gov/ct2/show/NCT00279201?term=%22Eli+Lilly+and+Company%22&rank=23
This study has been completed and has results
Sponsor: Eli Lilly and Company
Information provided by: Eli Lilly and Company
ClinicalTrials.gov Identifier: NCT00279201
First received: December 15, 2005
Last updated: January 24, 2011
Last verified: January 2011
Visual Summary created by WebSummarizer